Assessing the Use of Medical Insurance Claims and Electronic Health Records to Measure COVID-19 Vaccination During Pregnancy
Insurance claims data captured a larger proportion of COVID-19 vaccine doses than EHR data, and this proportion increased over time. Combining data from multiple administrative health records sources can improve COVID-19 vaccine measurement before and during pregnancy and may be important to reduce bias in studies of vaccine effects.
Authors
- Flor M. Muñoz
- Stacey Rowe
- Annette K. Regan
- Onyebuchi A. Arah
- Matthew M. Coates
Institutions
- Kaiser Permanente (US)
- University of California, Los Angeles (US)
- Baylor College of Medicine (US)
- Aarhus University (DK)
- UCLA Health (US)
- Monash University (AU)
- University of San Francisco (US)
Publication Details
- Journal
- Drug Safety
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1007/s40264-025-01641-7
- Primary Topic
- COVID-19 Impact on Reproduction
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Sanofi
- Gilead Sciences
- Novavax
- Moderna
- Seqirus
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases